[HTML][HTML] Anemia of chronic diseases: wider diagnostics—better treatment?

M Wiciński, G Liczner, K Cadelski, T Kołnierzak… - Nutrients, 2020 - mdpi.com
Anemia of chronic diseases is a condition that accompanies a specific underlying disease,
in which there is a decrease in hemoglobin, hematocrit and erythrocyte counts due to a …

[HTML][HTML] Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice

J Rottembourg, G Rostoker - Nephrologie & therapeutique, 2015 - jle.com
Background Metabolic acidosis (MAC) is a common aspect of dialysis-dependent patients. It
is definitely caused by acid retention; however, the influence of other plasma ions is unclear …

Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis

S Chakraborty, S Ghosh, A Banerjea… - Indian journal of …, 2016 - journals.lww.com
Objectives: To study medicine prescribing pattern for chronic kidney disease (CKD) patients
on maintenance hemodialysis. Materials and Methods: This prospective observational study …

Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders

CS Bajait, SA Pimpalkhute, SD Sontakke… - Indian journal of …, 2014 - journals.lww.com
Objectives: Patients with chronic kidney disease (CKD) suffer with multiple comorbidities
and complications like secondary hyperparathyroidism and hyperphosphotemia. Altered …

Distinct immunologic effects of different intravenous iron preparations on monocytes

LH Fell, AM Zawada, KS Rogacev… - Nephrology Dialysis …, 2014 - academic.oup.com
Background Iron deficiency contributes to anaemia in patients with chronic kidney disease.
Iv iron is therefore widely used for anaemia treatment, although it may induce oxidative …

A Retrospective Study on Drug Utilization Evaluation and Outcomes Assessment in the Department of Nephrology of Tertiary Care Multi speciality Teaching Hospital

M Jagadeesan, TM Vijayakumar - Research Journal of …, 2022 - indianjournals.com
Chronic kidney disease (CKD) is the major global health problem with increasing incidence
and comorbidities. These patients require life-long treatment with a wide class of drugs …

La prise en charge de l'anémie et de ses conséquences chez les patients débutant l'hémodialyse: importance du fer intraveineux en prédialyse

J Rottembourg, Y Sonigo, A Dansaert… - Néphrologie & …, 2013 - Elsevier
Résumé L'anémie est un symptôme fréquent chez les patients atteints de maladie rénale
chronique (MRC), débutant un traitement par hémodialyse (HD), corrigé par un apport …

Pharmacoeconomics and Utilization of Intravenous Iron Sucrose in a Tertiary Care Hospital

PM Kadam, S Tiwari, B Daswani… - Journal of Pharmaceutical …, 2024 - jpc.tums.ac.ir
Background: Rational utilization of parenteral iron with meticulous calculated doses will
promote appropriate utilization of healthcare resources. The aim is to study utilization of …

Intravenous iron during predialysis period improves anemia management and cardiovascular parameters in incident hemodialysis patients

J Rottembourg, Y Sonigo, A Dansaert… - Néphrologie & …, 2013 - jle.com
R É SUM É L'ané mie est un symptôme fré quent chez les patients atteints de maladie ré
nale chronique (MRC), dé butant un traitement par hé modialyse (HD), corrigé par un apport …

Utilisation des dérivés injectables du fer au cours de la maladie rénale chronique: intérêts, limites et conseils pour un bon usage

J Rottembourg, G Rostoker - Néphrologie & Thérapeutique, 2015 - Elsevier
Résumé La carence en fer est un problème clinique important au cours de la maladie rénale
chronique (MRC), faisant le lit de l'anémie par carence martiale et perturbant le métabolisme …